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CORRESPODENCE 
 
Yersinia enterocolitica is a gram-negative coccobacillus acquired by 
humans via oral route. It is associated with a wide spectrum of clinical and 
immunological manifestations, responsible for digestive diseases, including 
enterocolitis and mesenteric adenitis, as well as extra-digestive 
manifestations including respiratory tract and urinary tract infection, osteo-
articular infection, erythema nodosum and endocarditis [1]. Bacteremia and 
sepsis are most often reported in patients with predisposing underlying 
disease, such as an iron-overloaded state (haemochromatosis, acute iron 
poisoning), immunosuppressive therapy, diabetes mellitus, alcoholism, 
cirrhosis or malnutrition. It is associated with a high mortality of 25 to 50% [2]. 
Infective endocarditis (IE) is a rare manifestation of Yersinia enterocolitica 
infection. Only 15 cases of Yersinia enterocolitica endocarditis have been 
published so far.  
A 75-year-old man was admitted to our hospital because of high fever 
accompanied by chills and rigors that lasted for 7 days before admission. On 
the second day of high fever he felt pain and swelling of the left lower leg. The 
patient was in his usual state of health except for a medical history of arterial 
hypertension treated with amlodipine and cilazapril. A history of eating 
imported fish from Norway was recorded. On clinical examination his 
temperature was 38.2 °C, blood pressure 160/90 mm/Hg, and his pulse rate 
was 106 beats/min. The heart rhythm was regular and a grade 3/6 
holosystolic ejection murmur was heard at the apex. Left lower leg and foot 
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were edematous and Homan`s sign was positive. The patient felt no pain in 
the abdomen. Hematocrit was 48%, leukocytes 20900/mm3 with 91% 
neutrophils, platelets 199000/ mm3, ESR 74 mm/h and urine analysis was 
normal. Glucose levels were normal. Total bilirubin was 42.8 µmol/L (direct 
20.2; indirect 22.6), SGOT 72 U/L, SGPT 169 U/L, γ-GT 328 and alkaline 
phosphatase 372 U/L. The chest X-ray was normal. Electrocardiogram 
suggested left atrium and left ventricle hypertrophy. Ultrasound examination 
revealed multiple gallstones and calculosis of both kidneys. Three sets of 
blood cultures were taken and therapy with amoxicillin/clavulanic acid 1.2 g 
q8h IV plus gentamicin 240 mg once daily was initiated. Stool culture was 
negative but only on MacConkey and XLD agars. All blood cultures 
(BacT/ALERT FN and BacT/ALERT FA) were positive for Y. enterocolitica, 
serotype O:3. Current NCCLS (CLSI) guidelines were used. The strain was 
susceptible to amoxicillin (MIC 0.19 µg/ml), cefuroxime (MIC 1.5 µg/ml), 
ceftriaxone (MIC 0.047 µg/ml), imipenem (MIC 0.047 µg/ml), amikacin (MIC 
1.5 µg/ml), netilmicin (MIC 0.75 µg/ml), gentamicin (MIC 0.75 µg/ml), 
ciprofloxacin (MIC 0.012 µg/ml), trimethoprim sulfamethoxazole, piperacillin 
and cefoperazone. Cardiac murmur suggested possible infective endocarditis. 
A transthoracic echocardiogram revealed a tricuspidal valve vegetation 5 mm 
large near the septal cusp with mild regurgitation. The patient was treated with 
ampicillin 2.0 g IV q6h for 19 days plus gentamicin 240 mg once daily for 14 
days. Defervescence occurred after 7 days of treatment. Maculopapular rash 
appeared on day 19 suggesting allergy to ampicillin. The treatment with 
ampicillin was changed to ciprofloxacin 400 mg IV q12h for the next 23 days. 
The liver parameters normalised four weeks after admission. 
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Echocardiography on day 37 showed organization of the vegetation on 
tricuspidal valve with same level of regurgitation. No relapses were observed 
during the 26 months of follow up. 
Yersinia enterocolitica is a rare cause of infective endocarditis. Among 
1779 patients with IE included in the International Collaboration on 
Endocarditis – Prospective Cohort Study [3] this is the only case of Yersinia 
endocarditis (Correy R, personal communication). This is the first case of any 
native tricuspidal valve involvement without previously implanted pacemaker 
or known valvular disease and concomitant septic phlebitis. Only one patient 
had previously been reported with tricuspidal valve endocarditis but it was 
associated with contamination of previously implanted pacemaker [4]. 
 Except for age, no other predisposing factors for Yersinia bacteremia 
were present in our patient. We assume that deep septic phlebitis is a 
consequence of gut-origin septicaemia with Y.enterocolitica. Right-side 
endocarditis suggests that septic phlebitis was primary infection. Conservative 
treatment with ampicillin and subsequent ciprofloxacin was successful and 
there was no need for valvular replacement. Concomitant treatment included 
heparin followed by warfarin for deep venous thrombosis. 
Available data on twelve of fifteen previously reported patients with 
yersinial IE are presented in Table 1. Acute presentation affecting the mitral 
valve was recorded in 3 patients, aortic valve in 2 patients or both valves in 1 
patient. Native valve endocarditis dominated with only two cases of prosthetic 
valve endocarditis. Multiple blood cultures were positive in all patients. Three 
patients died of septicemia and one of them had liver failure. All three patients 
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had mitral valve vegetations and autopsies confirmed the presence of valve 
vegetations. 
The possibility of endocarditis should be taken into account in all 
patients with several positive blood cultures. Similar cases were reported by 
Appelbaum et al. [5] and Karachalios et al. [6]. Most of the published studies 
report that endocarditis due to Y. enterocolitica was treated with β-lactams 
and/or aminoglycosides [7, 8]. Our patient was successfully treated with a 
combination of ampicillin and gentamicin but because of an adverse event, 
the therapy was changed to ciprofloxacin as a single antibiotic regimen.
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Table 1. Clinical characteristics and laboratory findings in 13 cases of Yersinia enterocolitica endocarditis 
_________________________________________________________________________________________________________________________________________________________________________________________________ 
 
Case Number         Reference           Age (years)/Gender             Clinical presentation           TTE                                Positive/          Therapy  Outcome   
                                                              total blood cultures    
        1                             10                       68 /M                     Fever, right hemiparesis,         No data                       Unknown        Gentamicin  died of septicemia 
                                                                                              brain, liver and spleen infarcts         (2cm vegetation on MV histologically confirmed) 
        
        2                             11                       72 /M                            Fever, chills     Mitral valve                             7/7          Ampicillin +  died of septicemia          
      vegetations                                                                 gentamicin (vegetations on MV and abscess on mitral ring) 
 
        3                              5                        73 /M                   Fever, myalgia, vomiting,      Aortic valve                             2/2           Tobramycin  recovered 
                                                                                                          septic skin infarcts                                  vegetations 
 
        4                              2                        61/M                                Unknown                                           Aortic valve                                            Unknown                          Doxycycline,                        recovered 
        vegetations                                gentamicin,     
                                  trimethoprim-     
                                                                                                    sulfamethoxazole 
        5                            12                        58/M                            Fever, jaundice,      No vegetations                               3/3             Ampicillin,                died of septicemia and liver failure 
                                                                                                              liver failure                  followed by  (vegetations on MV histologically confirmed)
                  cefuroxime +     
                                                    gentamicin +     
                                                    metronidazole 
 
        6                            13                        72/M                       Fever, diarrhea, spleen,         Mitral and                                              6/6               Cefoxitin   recovered 
                                                                                                       liver and bone infarcts         aortic valve 
         vegetations 
 
        7                            14                        74/ F                          Fever, weakness       No vegetations                           4/4               Ceftizoxime   recovered 
 
        8                              4                        56/M                           Fever, diarrhea,       No vegetations                           5/6               Ceftriaxone +   recovered 
                                                                                                          left hemiparesis,                                                                                                                                                   gentamicin 
                                                                                                             brain infarct                                                
                
        9                             7                         45/M                        Fever, nausea, vomiting           No vegetations                           3/3                Cefamandole + recovered  
                                                                                                             spleen infarct                       tobramycin,            (fibrinous vegetations  
                       then imipenem          on posts and ring of 
        and finally  removed valve; 
        ceftriaxone                 no histology done) 
       
      10                             8                         68/M                                 Fever                                                   Mitral valve                                             3/3                Ciprofloxacin +               recovered 
           vegetation                                            netilmycin 
 
      11                             9                         89/M                         Fever with skin lesions        Tricuspid valve                                         3/3                 Ceftriaxon +                   recovered 
            vegetation                                                                                            ofloxacin 
                                                                                                                                     
      12                             6                         58/M                              Fever, malaise,                                       Mitral valve                                             3/3                   Netilmycin +   recovered 
                                                                                                                ecchymoses            vegetations                                                       ofloxacin 
       
      13                  (present case)               75 /M                          Fever, chills, rigors,                                   Tricuspid valve                                        3/3                   Ampicillin +  recovered 
                                                                                                        deep venous thrombosis            vegetation                                                                                           gentamicin 
        then ciprofloxacin 
M = male; F = female;  MV = mitral valve; TTE = transthoracic echocardiogram 
